Results 221 to 230 of about 1,360,875 (361)

Development and validation of a leukemia prognostic model through single-cell RNA sequencing and machine learning approaches. [PDF]

Discov Oncol
Chen D, Yang J, Wang M, Jian T.
europepmc   +1 more source

IS LEUKEMIA A DISEASE OF THE RETICULO-ENDOTHELIAL SYSTEM? [PDF]

, 1948
Bruce K. Wiseman
openalex   +1 more source

CXCR1 Depletion in Ly6C+ cDC2 Alleviates Acute Lung Injury via Modulation of Th17/Treg Balance

Advanced Science, EarlyView.
Pro‐inflammatory Ly6C⁺ cDC2s are identified as key effector cells mediating Cxcr1 signaling, driving the progression of ALI. Ly6C⁺ cDC2s release high levels of Il‐6 and Il‐1β, inducing Th17 differentiation. Cxcr1 deficiency reduces Il‐6 and Il‐1β production from Ly6C⁺ cDC2s through suppressing MEK1/ERK /NF‐κB signaling, thereby shifts naïve T cells ...
Shenghui Li, Wei Zhuang, Yang Wang, Hao Qin, Xichun Qin, Xianliang Yan, Xuefei Hu, Xiucheng Liu, Chang Chen   +8 more
wiley   +1 more source

The French-American-British classification system for acute myeloid leukemia. [PDF]

Haematologica
Pollyea DA.
europepmc   +1 more source

HTLV-1 viral oncogene HBZ induces osteolytic bone disease in transgenic mice [PDF]

, 2017
Esser, Alison K, et al,, Harding, John C, Ratner, Lee, Rauch, Daniel A, Ross, Michael H, Su, Xinming, Vij, Kiran, Weilbaecher, Katherine N, Wu, Kevin, Xiang, Jingyu, Xu, Yalin   +11 more
core   +2 more sources

Induction of Allergic Contact Dermatitis in Patients with the Lymphoma-Leukemia Complex**From the Department of Dermatology (Donald M. Pillsbury, M.D., Director), School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

, 1958
William L. Epstein
openalex   +1 more source

β-glucuronidase studies in stem-cell leukemias [PDF]

, 1954
A. J. Anlyan
openalex   +1 more source

Interactions of Antibody Drug Conjugate Anti‐Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy

Advanced Science, EarlyView.
Antibody drug conjugates deliver their cytotoxic anti‐tubulin or topoisomerase I inhibitor payloads to tumors through cancer cell receptor targeting. The released drug payloads induce cellular changes that interact with radiotherapy resulting in radiosensitization that improves cancer cell kill and stimulates anti‐tumor immune responses.
Jacqueline Lesperance, Bryan S. Yung, Michael M. Allevato, Marcus M Cheng, Maria F. Camargo, Robert Saddawi‐Konefka, Kanika Dhawan, Ashwyn K. Sharma, Mahsa Mortaja, Sophie Bice, Daniel J. Scanderbeg, Diego Alvarado, Jyoti Mayadev, Ramez N. Eskander, Stephen R. Adams, Pippa F. Cosper, J. Silvio Gutkind, Sunil J. Advani   +17 more
wiley   +1 more source

Acute heart failure in patients with hematologic malignancies: A nationwide analysis 2016-2021. [PDF]

SAGE Open Med
Prashanth Sivasubramanian B, Ravikumar DB, Yarrarapu SNS, Saravanabavanandan R, Sharieff II, Joshi S, Karunakar D, Vairavan VK, Balamurugan ID, Thirupathy U, Venkata VS, Garg Y, Ghosh AK.   +12 more
europepmc   +1 more source

CARBAMATES IN THE CHEMOTHERAPY OF LEUKEMIA [PDF]

, 1948
Howard E. Skipper, WILLIAM H. RISER, Anne Stelzenmuller, Helen Holt   +3 more
openalex   +1 more source